Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 620-056-5 | CAS number: 874195-61-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 04 March - 23 April 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 010
- Report date:
- 2010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5300 - In vitro Mammalian Cell Gene Mutation Test
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Ministerium für Arbeit, Gesundheit und Soziales des Landes Nordrhein-Westfalen
- Type of assay:
- mammalian cell gene mutation assay
Test material
- Reference substance name:
- N-[2-(4,6-dimethoxy-1,3,5-triazine-2-carbonyl)-6-fluorophenyl]-1,1-difluoro-N-methylmethanesulfonamide
- EC Number:
- 620-056-5
- Cas Number:
- 874195-61-6
- Molecular formula:
- C14H13F3N4O5S
- IUPAC Name:
- N-[2-(4,6-dimethoxy-1,3,5-triazine-2-carbonyl)-6-fluorophenyl]-1,1-difluoro-N-methylmethanesulfonamide
Constituent 1
Method
- Target gene:
- HPRT locus
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media:
*cell culture medium: PAA Ready Mix (10% FBS): Eagle's minimal essential medium (MEM, Earle) containing 1% L-glutamine, 1% MEM-vitamins, 1% MEM NEAA, 1% Pen/Strep and 10% FBS(foetal bovine serum);
*medium during treatment: PAA Ready Mix (2% FBS): Eagle's minimal essential medium (MEM, Earle) containing 1% L-glutamine, 1% MEM-vitamins, 1% MEM NEAA, 1% Pen/Strep and 2% FBS
*medium for selction of mutants: PAA Ready Mix (10% FBS) containing 10 µg/mL of 6-thioguanine (6-TG)
- Properly maintained: yes
- Periodically checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: yes
- Metabolic activation:
- with and without
- Metabolic activation system:
- co-factor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Aroclor 1254
- Test concentrations with justification for top dose:
- Experiment I
Without S9 mix: 25, 50, 100, 200, 400, 600, 800 µg/mL
With S9 mix: 25, 50, 100, 200, 400, 600, 800 µg/mL
Experiment II
Without S9 mix: 25, 50, 100, 200, 400, 600, 800 µg/mL
With S9 mix: 25, 50, 100, 200, 400, 600, 800 µg/mL - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The test substance was soluble up to 410 mg/mL in DMSO.
Controls
- Untreated negative controls:
- yes
- Remarks:
- Medium
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Remarks:
- ethylmethanesulphonate (EMS), 900 µg/mL with S9; dimethylbenzanthracene, 20 µg/mL in DMSO, without S9
- Positive control substance:
- ethylmethanesulphonate
- other: Dimethylbenzanthracene
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration: 5 h with and without metabolic activation
- Expression time (cells in growth medium): 6 days
- Selection time: 6-8 days
- Fixation time (start of exposure up to fixation or harvest of cells): 13-15 days
SELECTION AGENT (mutation assays): 10 µg/mL 6-TG
NUMBER OF REPLICATIONS: duplicates each in two independent experiments
DETERMINATION OF CYTOTOXICITY
- Method: cloning efficiency; relative population growth - Evaluation criteria:
- Mutant frequencies will only be used for assessment, if at least 5 dishes per culture were available and relative survival to treatment, relative population growth and absolute cloning efficiency were 10% or greater.
A trial will be considered positive if a concentration-related and in parallel cultures reproducible increase in mutant frequencies is observed. To be relevant, the increase in mutant frequencies should be at least two to three times that of the highest negative or negative control value observed in the respective trial. If this result can be reproduced in a second trial, the test substance is considered to be mutagenic.
Despite these criteria, a positive result will only be considered relevant, if no significant change in osmolality compared to the negative control can be observed. Otherwise, unphysiological culture conditions may be the reason for the positive result (Scott et al., 1991, Mutation Res. 257, 147-204).
A test substance will be judged as equivocal if there is no strictly concentration related increase in mutation frequencies but if one or more concentrations induce a reproducible and biologically relevant increase in mutant frequencies in all trials.
An assay will be considered negative if no reproducible and relevant increases of mutant frequencies were observed. - Statistics:
- All acceptable groups are included in the weighted analysis of variance followed by pairwise comparisons to the negative control on a nominal significance level of alpha = 0.05 using the Dunnett test (Dunnett, 1955). The regression analysis part is performed on the basis of the actual concentrations thereby omitting the positive, untreated and negative controls. If there is a significant concentration related increase of the mutant frequency (alpha = 0.05) in the main analysis the highest concentration will be dropped and the analysis will be repeated. This procedure will be repeated until p > 0.05. In that way eliminated concentrations are flagged correspondingly.
Results and discussion
Test results
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: Concentrations of up to 800 µg/mL test substance did not change the pH in the medium of the pre-test.
- Effects of osmolality: The osmolality in the medium of the pre-test was not changed by concentrations of up to 800 µg/mL test substance.
- Precipitation: Without and with S9 mix substance precipitation occurred in the medium at the concentration 600 µg/mL and above.
COMPARISON WITH HISTORICAL CONTROL DATA: The results of the controls are in the range of historical controls.
ADDITIONAL INFORMATION ON CYTOTOXICITY: No cytotoxic effects above 80% were induced by the used concentrations in a pre-test. However, precipitation of the test substance in the culture medium started at 600 µg/mL. Due to these findings, the test substance was tested in the mutation experiments in concentrations ranging from 25 µg/mL to 800 µg/mL without and with metabolic activation. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
In the absence and in the presence of S9 mix Chinese hamster V79 cells were exposed to the test substance at concentrations of up to and including 800 µg/mL. The means of the absolute cloning efficiency for the negative controls in the mutation experiments were 56.4% and 93.4% in the experiments without activation. In experiments with metabolic activation 90.7% and 93.2% were observed. These results demonstrate good cloning conditions for the experiments.
Two independent experiments were performed with and without S9 mix (Tables 1-4). The mutant frequencies of the untreated controls and of the solvent controls were all within the normal range. The positive controls induced clear mutagenic and statistically significant effects in all trials. The test substance did not induce cytotoxic effects of 80% to 90% both with and without metabolic activation. However, the test substance was tested up to at least its limits of solubility in the medium. The test substance induced no relevant increases in mutant frequencies with and without metabolic activation. In addition, the overall statistical analysis reveals no statistically significant increase. Therefore, neither with nor without S9 mix, the test substance was evaluated as non-mutagenic.
Table 1: Experiment I - Without Metabolic Activation
Concentration |
Cloning efficiency [%] |
Relative Population Growth [%] |
Mutant Frequency x 106 |
Negative control |
71.7±3.8 |
118.2 |
1.2 |
60.0±3.5 |
151.3 |
2.1 |
|
DMSO |
60.7±3.3 |
100 |
2.1 |
52.0±5.6 |
100 |
0.8 |
|
25 |
51.5±3.6 |
97.0 |
3.2 |
62.5±3.5 |
146.8 |
0.0 |
|
50 |
69.7±4.6 |
75.3 |
4.8 |
60.2±1.3 |
137.9 |
4.2 |
|
100 |
59.8±0.8 |
87.9 |
0.7 |
60.0±2.2 |
147.4 |
1.4 |
|
200 |
57.2±2.8 |
110.5 |
2.2 |
58.0±2.8 |
130.4 |
0.7 |
|
400 |
58.3±4.5 |
84.9 |
1.4 |
64.2±2.5 |
129.2 |
0.6 |
|
600 P |
52.8±5.5 |
122.3 |
2.4 |
68.0±4.4 |
125.0 |
0.6 |
|
800 P |
55.3±2.1 |
107.2 |
1.5 |
61.5±9.0 |
158.7 |
0.0 |
|
EMS, 900 |
46.3±3.2 |
19.3 |
624.1 |
38.7±9.0 |
30.3 |
574.4 |
EMS: Ethylmethanesulphonate
P: Precipitate
Table 2: Experiment I - With Metabolic Activation
Concentration |
Cloning efficiency [%] |
Relative Population Growth [%] |
Mutant Frequency x 106 |
Negative control |
91.2±8.1 |
128.9 |
3.2 |
84.8±2.8 |
75.1 |
4.9 |
|
DMSO |
96.3±4.0 |
100 |
6.9 |
90.0±3.8 |
100 |
2.8 |
|
25 |
77.3±7.8 |
120.6 |
7.5 |
88.2±4.9 |
82.1 |
4.7 |
|
50 |
81.2±2.8 |
129.3 |
13.3 |
88.0±5.9 |
92.5 |
8.5 |
|
100 |
81.8±0.3 |
117.0 |
7.6 |
91.3±3.2 |
81.7 |
7.3 |
|
200 |
87.5±3.0 |
94.5 |
4.8 |
76.3±2.8 |
108.5 |
2.7 |
|
400 |
93.7±3.1 |
115.9 |
5.8 |
93.3±0.8 |
63.8 |
11.6 |
|
600 P |
86.2±8.8 |
106.5 |
8.7 |
85.0±5.6 |
85.6 |
4.9 |
|
800 P |
90.3±1.5 |
80.0 |
10.6 |
96.7±7.5 |
77.1 |
3.9 |
|
DMBA |
83.5±3.3 |
61.7 |
141.7 |
83.7±3.3 |
25.1 |
151.4 |
DMAM: dimethylbenzanthracene
P: Precipitate
Table 3: Experiment II - Without Metabolic Activation
Concentration |
Cloning efficiency [%] |
Relative Population Growth [%] |
Mutant Frequency x 106 |
Negative control |
66.8±5.3 |
64.1 |
4.4 |
75.5±3.9 |
107.2 |
3.9 |
|
DMSO |
92.7±4.9 |
100 |
0.4 |
94.0±5.3 |
100 |
6.2 |
|
25 |
89.5±4.4 |
151.4 |
3.3 |
93.0±6.5 |
102.6 |
1.8 |
|
50 |
90.2±7.0 |
130.7 |
1.8 |
82.7±6.3 |
108.3 |
3.5 |
|
100 |
96.7±6.8 |
155.7 |
2.2 |
88.8±2.0 |
123.0 |
1.9 |
|
200 |
65.2±8.1 |
37.8 |
3.8 |
93.7±8.5 |
83.7 |
3.1 |
|
400 |
88.7±5.8 |
86.5 |
0.5 |
92.5±6.5 |
108.9 |
0.5 |
|
600 P |
101.7±3.2 |
100.6 |
2.5 |
97.5±6.8 |
117.1 |
1.3 |
|
800 P |
95.5±6.8 |
97.7 |
3.5 |
85.2±5.0 |
114.9 |
4.9 |
|
EMS, 900 |
56.7±4.8 |
51.6 |
1212.5 |
68.0±2.3 |
27.5 |
890.3 |
EMS: Ethylmethanesulphonate
P: Precipitate
Table 4: Experiment II - With Metabolic Activation
Concentration |
Cloning efficiency [%] |
Relative Population Growth [%] |
Mutant Frequency x 106 |
Negative control |
87.8±1.3 |
108.9 |
3.3 |
90.0±2.3 |
97.9 |
1.4 |
|
DMSO |
88.5±11.8 |
100 |
6.1 |
92.8±5.1 |
100 |
3.1 |
|
25 |
87.0±0.7 |
83.9 |
5.7 |
79.2±9.0 |
100.4 |
5.3 |
|
50 |
85.2±3.4 |
118.9 |
3.4 |
81.0±6.1 |
106.0 |
2.1 |
|
100 |
78.2±3.5 |
166.1 |
6.4 |
94.0±7.5 |
79.3 |
11.5 |
|
200 |
83.2±2.9 |
111.7 |
10.0 |
84.7±4.4 |
92.7 |
5.4 |
|
400 |
84.7±1.9 |
116.5 |
4.4 |
77.8±6.8 |
87.0 |
4.8 |
|
600 P |
81.7±4.2 |
123.2 |
10.2 |
76.7±5.0 |
100.8 |
8.7 |
|
800 P |
86.5±6.9 |
106.5 |
4.3 |
78.2±5.3 |
89.2 |
13.3 |
|
DMBA 20 |
89.0±6.6 |
16.5 |
126.9 |
83.3±3.0 |
14.6 |
100.5 |
DMAM: dimethylbenzanthracene
P: Precipitate
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.